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Background and purpose — The risk of complications in cirrho-
sis patients after orthopedic surgery is unclear. We examined this 
risk after total hip arthroplasty (THA) or total knee arthroplasty 
(TKA).
Patients and methods — Using Danish healthcare registries, we 
identified all Danish residents who underwent a THA or TKA for 
primary osteoarthritis in the period 1995–2011. We compared the 
risk of complications in patients with or without cirrhosis. 
Results — The surgical technique was similar in the 363 cir-
rhosis patients and in 109,159 reference patients, but cirrhosis 
patients were more likely to have been under general anesthesia 
(34% vs. 23%), were younger (median age 66 vs. 69 years), had 
a predominance of males (54% vs. 41%), had more comorbid-
ity, and had had more hospitalizations preoperatively. Their risk 
of intraoperative complications was similar to that for refer-
ence patients (2.5% vs. 2.0%), but they had greater risk of dying 
during hospitalization or within 30 days of discharge (1.4% vs. 
0.4%; aOR = 3.9, 95% CI: 1.5–10); greater risk of postoperative 
transfer to an intensive care unit (0.6% vs. 0.06%; aOR = 5.8, CI: 
1.3–25) or a medical department (4.4% vs. 2.5%; aOR = 1.7, CI: 
0.99–2.9); greater risk of readmission within 30 days of discharge 
(15% vs. 8%; aOR = 1.8, CI: 1.3–2.4); and greater risk of deep 
prosthetic infection (3.1% vs. 1.4%) or revision (3.7% vs. 1.7%) 
within 1 year. The chance of having an uncomplicated procedure 
was 81.0% (CI: 76.6–85.0) for cirrhosis patients and 90.0% (CI: 
89.6–90.0) for reference patients.
Interpretation — Cirrhosis patients had a higher risk of post-
operative complications after THA or TKA for primary osteoar-
thritis than patients without cirrhosis. This may have implications 
for orthopedic surgeons’ postoperative management of cirrhosis 
patients, and preoperative assessment by a hepatologist may be 
indicated.

Liver cirrhosis is the common end stage of all chronic liver 
diseases, and it affects about 0.2% of the Danish population. 
Alcohol is by far the most common cause of cirrhosis in Den-
mark. The number of total hip arthroplasties (THAs) and total 
knee arthroplasties (TKAs) performed is on the increase. Thus, 
it is also likely that more cirrhosis patients will undergo THA 
or TKA, particularly with the growing number of patients 
with cirrhosis related to obesity and non-alcoholic fatty liver 
disease. In cirrhosis patients, their portal hypertension, hyper-
dynamic circulation, and acquired immune deficiency  is asso-
ciated with an increased risk of complications after abdominal 
surgery (Ziser et al. 1999, Thulstrup et al. 2001, Nielsen et al. 
2002, Friedman 2010), but it is unclear whether these patients 
also have an increased risk of complications after elective 
THA or TKA. What is known rests on only 4 small studies 
with selected patients (Hsieh et al. 2003, Shih et al. 2004, 
Cohen et al. 2005, Moon et al. 2007). They indicated that cir-
rhosis patients—particularly those with advanced cirrhosis—
have an increased risk of developing complications. However, 
these studies involved patients treated for various conditions, 
and it is unclear whether the findings also apply to patients 
treated for osteoarthritis. We therefore examined the risk of 
complications after THA or TKA for primary osteoarthritis 
in cirrhosis patients. We expected that the cirrhosis patients 
would have a higher risk of complications than patients with-
out cirrhosis.
  
patients and methods
Sources of data
We performed a historical cohort study that involved linkage 
of public healthcare registries with clinical databases. All 5.6 
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million residents of Denmark can be diagnosed and treated 
free of charge within the tax-funded public healthcare system. 
The Danish National Patient Registry (NPR) is a nationwide 
registry of hospital admissions since 1977 and of outpatient 
and emergency room visits since 1995 (Andersen et al. 1999). 
The data comprise relevant dates and discharge diagnoses 
coded in accordance with the International Classification of 
Diseases, edition 10 (ICD-10) since 1994 and ICD-8 before 
that. The Danish Hip Arthroplasty Registry  (DHAR) and the 
Danish Knee Arthroplasty Registry (DKAR) hold data on all 
patients who have undergone a primary or revision THA or 
TKA in Denmark since January 1, 1995 (DHAR) or Janu-
ary 1, 1997 (DKAR) (Dansk Hoftealloplastik Register 2010, 
Dansk Knæalloplastik Register 2010, Robertsson et al. 2010, 
Pedersen et al. 2012). Every public and private orthopedics 
department in Denmark reports to these clinical databases—
which are 97% and 92% complete, respectively (Pedersen et 
al. 2004, 2012). The operating surgeon provides data on the 
indication for surgery (primary or secondary osteoarthritis, 
rheumatic arthritis, fracture, congenital hip dysplasia, avas-
cular necrosis of the femoral head, or other indication), type 
of operation (primary or revision), type of anesthesia (general 
or regional), antibiotic use, prosthesis components and fixa-
tion, intraoperative complications, and revision. Individual-
level data from the NPR and the DHAR/DKAR were linked 
through the unique personal identification number issued by 
the Danish Central Office of Civil Registration to all Danish 
citizens at birth or to immigrants. This registry also records 
the date of death or emigration for all Danish citizens and is 
continuously updated (Pedersen et al. 2006). 
Study population and comorbidity
We included all Danish residents who underwent THA and 
TKA for primary osteoarthritis between January 1, 1995 and 
December 31, 2011 according to the DHAR and DKAR, and 
we only considered their first hip or knee arthroplasty. Those 
of them who had received 1 or more discharge diagnosis codes 
for cirrhosis (ICD-10: K70.3, K70.4, K74.6; ICD-8: 571.09, 
571.92, 571.99) before the hip or knee arthroplasty were cat-
egorized as cirrhosis patients. The remaining patients were 
categorized as reference patients. Cirrhosis patients were fur-
ther subcategorized into cirrhosis patients with clinically sig-
nificant portal hypertension—defined as 1 or more diagnoses 
with bleeding esophagus varices (ICD-10: I85.0), gastric vari-
ces (ICD-10: I86.4), or portal hypertension (ICD-10: K76.6) 
before the THA or TKA—and cirrhosis patients without 
portal hypertension. For each cirrhosis patient and each refer-
ence patient, we identified all discharge diagnoses in the NPR 
from in-hospital admissions in the 5 years before the THA 
or TKA. Using these data, we computed the patient’s Charl-
son comorbidity index (CCI), defined for usage with ICD-10 
codes (Quan et al. 2005). Liver disease was not a comorbidity 
in the present study, and it was therefore excluded from the 
CCI. 
Outcomes and statistical analysis
We computed mortality during hospitalization or within 30 
days of discharge, and the risk of complications with cor-
responding 95% confidence intervals (CIs). Complications 
included intraoperative complications, transfer to an intensive 
care unit (ICU), transfer to a medical department, and in-hos-
pital readmission within 30 days of hospital discharge. Using 
the discharge diagnosis codes shown in Table 3, we further 
categorized readmissions as being due to infection, liver dis-
ease, acute renal failure, venous thromboembolism, cardiovas-
cular disease, hip dislocation, or mechanical complications—
or as being due to other diagnoses. In the analysis of read-
missions for hip dislocation, we included hospital contacts in 
outpatient clinics. We used chi-square statistics for categorical 
variables and Student’s t-test for continuous variables to deter-
mine whether certain patient characteristics (age, gender, CCI, 
and number of inpatient hospitalizations in the year preceding 
arthroplasty) or procedural characteristics (operation site (hip 
or knee), type of anesthesia (regional or general), and year 
of operation) differed significantly between cirrhosis patients 
and reference patients. Logistic regression was used to com-
pute and compare adjusted odds ratios (aORs) of all outcomes 
for patients with cirrhosis and for reference patients. The 
odds ratios were adjusted for the patient characteristics and 
procedural characteristics listed above. We also calculated the 
probability of an uncomplicated THA or TKA, i.e. the propor-
tion of THAs or TKAs where the patients did not have any of 
the complications defined above. In addition, we repeated the 
analyses, restricting them to patients who were operated under 
regional anesthesia. Furthermore, we compared odds for cir-
rhosis patients with no clinically significant portal hyperten-
sion and for reference patients—regarding mortality during 
hospitalization or within 30 days of discharge, intraopera-
tive complications, transfer to an ICU, transfer to a medical 
department, and readmission to hospital within 30 days of 
hospital discharge. Finally, we computed the cumulative inci-
dence (i.e. risk) of deep prosthetic infection and revision in the 
first year after THA or TKA using competing-risk methods, 
with death as the competing risk (Satagopan et al. 2004), and 
we used competing-risk regression to adjust for the patient 
and procedural characteristics listed above (Fine et al. 1999). 
Each patient was followed from the date of THA or TKA for 
1 year after this date. Deep prosthetic infection was defined by 
NPR diagnoses (T84.5, T84.6, and T84.7), and revisions were 
identified in the DHR or DKR. All statistical analyses were 
performed using Stata software version 12.1 and R software 
version 2.14.1 (R Core Team 2013).
results
We included 363 patients with cirrhosis (59 of them with a his-
tory of clinically significant portal hypertension) and 109,159 
reference patients who underwent THA or TKA for primary 
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osteoarthritis in the period 1995–2011. Cirrhosis patients were 
generally younger, had male predominance, had more comor-
bidity, were more frequently hospitalized in the year before 
THA or TKA, and were more frequently under general anes-
thesia (Table 1). The median time from diagnosis of cirrhosis 
to THA or TKA was 6 years and 6 months.
The risk of intraoperative complications was similar for cir-
rhosis patients and for reference patients (2.48% vs. 1.98%, 
aOR = 1.3, CI: 0.7–2.5), whereas cirrhosis patients had higher 
risk of 30-day mortality (1.38% vs. 0.38%, aOR = 3.9, CI: 
1.5–9.7), of transfer to an ICU (0.55% vs. 0.055%, aOR = 5.8, 
CI: 1.3–25), of transfer to a medical department (4.41% vs. 
2.47%, aOR = 1.7, CI: 0.99–2.9), and of readmission (14.9% 
vs. 7.8%, aOR = 1.8, CI: 1.3–2.4) (Table 2). These aORs 
were essentially unaltered when we restricted our analyses to 
patients operated under regional anesthesia, or to the 304 cir-
rhosis patients with no clinically significant portal hyperten-
sion. Of the cirrhosis patients, those with clinically significant 
portal hypertension had higher 30-day mortality (1.7% vs. 
1.3%) and risk of transfer to an ICU (1.7% vs. 0.3%) than than 
those without any clinically significant portal hypertension.
The excess risk of readmission for cirrhosis patients was due to 
Table 1. Characteristics of the patient cohort
 Cirrhosis Reference p-value a
 patients patients
Number of cases 363   109,159   
Median age, years  66 69 < 0.01
 25th and 75th percentiles 59–71 62–76 
M/F, % 54/46 41/59 < 0.01
Hip/Knee, % 58/42 61/39  0.2
Charlson comorbidity index, %   < 0.01
    0  63 82 
    1 20 11 
    2 8  5 
 ≥ 3 9  2 
Number of inpatient hospitalizations 
in the year before hip or knee 
replacement, %   < 0.01
    0 53 77 
    1  23 15 
    2  12 5 
 ≥ 3 12 3 
Type of anesthesia
 regional/general, % 34/66 23/77 < 0.01
Year of operation Data not shown 0.6
a The p-value represents a comparison between the 2 groups using  
  chi-square test or Student’s t-test.
Table 2. Absolute risks (%) and adjusted odds ratios (aOrs) for complications after hip or knee 
replacement in cirrhosis patients and reference patients
  Cirrhosis patients Reference patients 
  risk (CI) risk   (CI) aOR a (CI)
Intraoperative complications  2.48 (1.14–4.65)  1.98   (1.90–2.06)  1.3 (0.7–2.5)
Mortality within 30 days 1.38 (0.45–3.18)  0.38   (0.34–0.42)  3.9 (1.5–10)
Transfer to an intensive care unit 0.55 (0.07–1.98)  0.055 (0.042–0.072)  5.8 (1.3–25)
Transfer to a medical department 4.41 (2.54–7.06)  2.47   (2.37–2.56)  1.7 (1.0–2.9)
Readmission within 30 days 14.9 (11.4–17.0)  7.84   (7.68–8.00)  1.8 (1.3–2.4)
a Adjusted for age, gender, Charlson comorbidity index, operation site (hip/knee), anesthesia 
  (general/regional), and number of inpatient hospitalizations in the year preceding hip or knee 
  replacement.
Table 3. Absolute risks (%) and odds ratios for readmission according to disease categories
 Cirrhosis patients Reference patients 
Disease category, ICD-10 code n     risk (CI) n     risk    (CI) aOR b
Infection, DAa, DB95a, DB96a, DJ1a, DJ9a, Dl0a, DM00a, DN30a, DT814     6   1.65 (0.61–3.56)    843   0.77   (0.72–0.83)  1.8 (0.8–4.2)
Liver disease, DK7 a    9   2.48 (1.14–4.65)       11   0.001 (0.0005–0.01)  257 (99–672)
Acute renal failure, DN0 a, DN1 a    2   0.55 (0.07–1.98)     107   0.010 (0.008–0.011)  3.4 (0.8–14)
Venous thromboembolism, DI80 a, DI81 a, DI82 a, DI83 a, DI26 a    2   0.55 (0.07–1.98)     702   0.64   (0.60–0.69)   0.8 (0.2–3.2)
Cardio vascular disease, DD65, DI60–DI64, DG45, DI2a      2   0.55 (0.07–1.98)     666   0.61   (0.56–6.58)   0.7 (0.2–2.9)
Hip dislocation c, DS73 a, DS83 a    1   0.82 (0.17–2.40)     279   0.48   (0.43–0.52)   1.5 (0.5–4.8)
Mechanical complications, DT840, DT841, DT842, DT843, DT844    7   1.93 (0.18–2.55)  1,145   1.05   (0.98–1.11)   1.7 (0.8–3.6)
Readmissions with other diagnoses, any other diagnosis  30   8.26 (5.41–11.1)  5,444   4.99   (4.86–5.12)  1.5 (1.0–2.2)
 
a Any number. 
b Confounder-adjusted odds ratio (aOR) are adjusted for age, gender, CCI, operation (hip/knee), anesthesia (general/regional), and number of 
   inpatient hospitalizations in the year preceding first hip or knee replacement.
c Including emergency room contacts.
infection, liver disease, or acute renal 
failure, while there was no excess risk 
of cardiovascular disease or venous 
thromboembolism (Table 3). Cirrho-
sis patients had a higher 1-year risk 
of deep prosthetic infection than ref-
erence patients (3.1% (CI: 1.6–5.2) 
vs. 1.4% (CI: 1.3–1.4)), and the dif-
ference remained after adjustment for 
patient characteristics and procedural 
characteristics (adjusted subdistribu-
tion hazard ratio = 2.1, CI: 1.3–3.7). 
Moreover, they were more likely to 
require a revision arthroplasty within 
a year (3.7% (CI: 2.1–6.1) vs. 1.7% 
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(CI: 1.6–1.8)). This association remained after adjustment 
(adjusted subdistribution hazard ratio = 1.9, CI: 1.1–3.3). The 
probability of having an uncomplicated hip or knee arthro-
plasty was 81% (CI: 77–85) for cirrhosis patients and 90% 
(CI:  89.6–90.0) for reference patients. 
Discussion
This nationwide registry-based historical cohort study showed 
that cirrhosis patients who underwent total hip or knee arthro-
plasty for primary osteoarthritis had a higher risk of dying, of 
postoperative transfer to an ICU or a medical department, of 
readmission, of revision, and of deep prosthetic infection than 
reference patients who underwent the same procedures. How-
ever, the majority (81%) of the cirrhosis patients did not have 
any complications and they did not have an increased risk of 
intraoperative complications. Cirrhosis patients had a particu-
larly high risk of readmission for infection, liver disease, or 
acute renal failure.
The strengths of our study were the nationwide population-
based design, the large size, and the complete follow-up in a 
uniform healthcare system. However, one limitation was that 
we did not assess the validity of our data sources. Between 1996 
and 2009, the completeness of the DHR increased from 92% 
to 97% and the completeness of the DKR increased from 86% 
to 92% (Dansk Hoftealloplastik Register 2010, Dansk Knæal-
loplastik Register 2010). We have no reason to believe that the 
few unregistered procedures involved cirrhosis patients with a 
particularly favorable or unfavorable outcome. The validity of 
cirrhosis diagnoses registered in the NPR is 85% (Vestberg et 
al. 1997), and erroneous diagnoses would have caused us to 
underestimate the excess risk for cirrhosis patients. The same 
bias would occur if outcome data were incorrect. It is possible 
that surgeons are less likely to report intraoperative complica-
tions in cirrhosis patients because they accept it as normal to 
have some difficulty with these patients. If so, this bias might 
explain the lack of association between cirrhosis and intra-
operative complications. All other complications were identi-
fied in independent data sources, and we believe that it would 
be unlikely for them to have been affected by reporting bias, 
although we have no validation. The validity of the mortality 
data originating from the Danish Central Office of Civil Reg-
istration is essentially 100% (Pedersen et al. 2006).
 Another limitation of the present study was the lack of data 
on alcohol intake and smoking, both of which are associated 
with a worse outcome after elective surgery (Nath et al. 2010, 
Singh 2011). There is an obvious association between alco-
hol intake and cirrhosis, and it is likely that smoking is also 
more common in cirrhosis patients. Alcohol intake increases 
the risk of infection in cirrhosis patients (Rosa et al. 2000), but 
we believe that THA and TKA are mainly offered to cirrho-
sis patients who do not drink alcohol. Finally, the confound-
ing effect of smoking is indirectly covered by our adjustment 
for chronic obstructive pulmonary disease and cardiovascular 
disease. Thus, alcohol and smoking may have contributed to 
the association between cirrhosis and postoperative complica-
tions, but we do not believe that it fully explains it.
A final limitation of this study was the lack of detailed data 
on the etiology of cirrhosis and on its severity. We suspect that 
most of the cirrhosis patients did in fact have alcoholic cir-
rhosis (Sørensen et al. 2003), so we chose to report outcomes 
jointly for all cirrhosis patients. The patients were presum-
ably in a compensated stage of their liver disease because the 
preoperative evaluation for such elective surgery would have 
identified and excluded patients with gross decompensation. 
Thus, our results indicate that even cirrhosis patients with a 
low perceived surgical risk have an increased risk of postop-
erative complications. This interpretation is supported by our 
finding that the cirrhosis patients with no clinically significant 
portal hypertension and those operated under regional anes-
thesia had an increased risk of postoperative complications. 
However, it is still meaningful to expect the risk to increase 
with the severity of the liver disease, in line with the previ-
ously reported higher risk according to the severity of portal 
hypertension (Hsieh et al. 2003, Moon et al. 2007). 
Our findings agree with the results of the 4 previously pub-
lished studies on cirrhosis patients who underwent THA or 
TKA, and 2 of them even found an increased risk of postop-
erative infections and acute renal failure (Hsieh et al. 2003, 
Cohen et al. 2005). Direct comparison is precluded by differ-
ences in indications for hip or knee arthroplasty and in patient 
selection. The latter difference is suggested by the markedly 
higher 30-day mortality estimates in the other studies (7–10% 
as opposed to 1.38% in the present study) (Cohen et al. 2005, 
Moon et al. 2007). 
In other types of surgery, odds ratios for 30-day mortal-
ity for cirrhosis patients relative to population controls have 
ranged from 3 to 12 (Poulsen et al. 2000, Nielsen et al. 2001, 
Thulstrup et al. 2001, Nielsen et al. 2002, Lund et al. 2003, 
Arif et al. 2012), the lowest odds ratio being for transurethral 
resection of the prostate (Nielsen et al. 2001) and the high-
est being for open cholecystectomy (Thulstrup et al. 2001). 
So, although THA and TKA are extra-abdominal proce-
dures performed in an elective setting, the relative increase 
in mortality ascribed to cirrhosis is comparable to that seen 
after other types of surgery. This indicates that the cirrhosis-
related excess risk is a systemic problem and is not restricted 
to intraperitoneal procedures. However, the present study did 
not address the question of whether cirrhosis patients with pri-
mary osteoarthritis should or should not be offered surgery; 
we merely provide the basis for an informed decision.
The mechanisms behind the increased surgical risk in cir-
rhosis patients are the subject of debate. Circulatory instabil-
ity introduced by anesthesia has been proposed (Friedman 
2010), but our estimates were unaltered when we excluded 
patients who were operated under general anesthesia, and this 
clearly indicates that other mechanisms contribute. Our find-
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ings rather implicate susceptibility to bacterial infections in 
cirrhosis patients as an important cause of their higher risk of 
having complications after surgery (Christou et al. 2007). In 
fact, a recent study of patients undergoing THA or TKA iden-
tified comorbid liver disease as the strongest predictor of deep 
prosthetic infection, increasing the odds 2.5-fold (Poultsides 
et al. 2013), and prosthetic hip infections in cirrhosis patients 
are difficult to eradicate (Hsieh et al. 2010). Suggested mech-
anisms for this susceptibility include translocation of bacte-
ria from the intestines, dysfunction of polymorphonuclear 
leukocytes, complement deficiency, and disturbance of the 
reticuloendothelial system (Møller et al. 2007). 2 studies have 
shown excessive activation of IL-6 and TNF-α in cirrhosis 
patients after surgery, and a subsequent acute-phase response 
(Sato et al. 1996, Lan et al. 2003); this hyperactivity offers a 
supplementary explanation for the increased surgical risk in 
cirrhosis patients. Thus, a number of different explanations 
for the higher surgical risk are possible, and the present study 
indicates that an increased susceptibility to infection is one of 
them—while intolerance to anesthesia is of minor importance.
In conclusion, cirrhosis patients undergoing total hip or 
knee arthroplasty for primary osteoarthritis have an increased 
risk of dying, of transfer to an ICU or a medical department, 
of deep prosthetic infection, of revision, and of readmission 
for infection, liver disease, or acute renal failure. Our results 
indicate that the risk applies to all cirrhosis patients and not 
only to severe cases. This may have implications for orthope-
dic surgeons’ degree of preoperative awareness of even dis-
crete signs of cirrhosis, and for the level of attention paid to 
liver-related problems.
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